MAFLD: What Is It?

Houston Methodist

D. Victor

Current Treatment of Metabolic Dysfunction Associated with Steatotic…

Indiana University School of Medicine Division of Gastroenterology and Hepatology

N. Samala

Alpha One - Antitrypsin Deficiency: More Common Than You Think

Kyle Hogarth

Best Practices In Managing NAFLD / NASH

MedNews Week

D. Bernstein

Chronic Viral Hepatitis B: Can We Expect a Cure?

Houston Methodist

M. Jones-Pauley

The Fatty Liver Disease Epidemic

UPMC

M. Klinge

Alcoholism is a Mid-brain Disease: Treat it as Such

Houston Methodist

H. Wetsman

Using Resmetirom (THR-β Agonist) in Your Practice for MASH

Scripps Health

J. Gutierrez

Evaluating Liver-Related Mortality and Liver Transplant Outcomes

Stanford Medicine

W. Ray Kim

Heart and Liver Interactions

Houston Methodist DeBakey Heart and Vascular Center

S. Adeel Ahsan

NASH Update 2023

Icahn School of Medicine at Mount Sinai

M. B. Bansal

Liver Lessons: Updates in Hepatitis Management Among PWH

UCSF School of Medicine

J. Briggs, J. Price

How to Manage Chronic Pain Associated with Enlarged and Heavy Kidney…

PKD Foundation

M. Hogan

Update on Hepatology Literature

UCLA Health

J. Benhammou, C. Wong

Cutting Edge Diagnostics and Treatment for NAFLD

Northwestern Medicine Gastroenterology

M. E. Rinella, L. Van Wagner

Case Presentation: A Difficult Case of Subacute Hepatitis

University of Miami

S. Condon

The Evolving Landscape of Non-Alcoholic Fatty Liver Disease (NAFLD) …

Cardiometabolic Health Congress (CMHC)

K. Cusi

Fatty Liver Disease: When to Refer?

Yale School of Medicine

NAFLD: Updates in Management

UChicago Medicine

M. E. Rinella